Pcv 2-based methods and compositions for the treatment of pigs
作者： Sui T. Lay , Michael G. Sheppard
DOI:
关键词:
摘要: The present invention relates to methods and compositions for vaccinating pigs against porcine circovirus type 2 (PCV2) associated diseases. In particular, the recombinant expression vectors allowing secretion or cell membrane of a truncated form PCV2 open reading frame (ORF2) protein.
lens.org 参考文章(12)
David V. Goeddel, Daniel J. Capon, Recombinant animal interferon polypeptides ,(1995)
Marc Eloit, Bernard Georges Klonjkowski, Viral vectors and viral vaccines based on recombinant porcine adenoviruses ,(2000)
Sylvia Van Den Hurk, Lorne A. Babiuk, David Fitzpatrick, Tim Zamb, Bovine herpesvirus type 1 polypeptides and vaccines ,(1988)
Ke Wang, Lihua Huang, Jian Kong, Xiaowei Zhang, Expression of the capsid protein of porcine circovirus type 2 in Lactococcus lactis for oral vaccination. Journal of Virological Methods. ,vol. 150, pp. 1- 6 ,(2008) , 10.1016/J.JVIROMET.2008.02.014
T B Ferreira, P M Alves, J G Aunins, M J T Carrondo, Use of adenoviral vectors as veterinary vaccines Gene Therapy. ,vol. 12, ,(2005) , 10.1038/SJ.GT.3302618
Simona Barzu-Le-Roux, Laurent Bernard Fischer, Jean-Christophe Francis Audonnet, DNA vaccines for farm animals, in particular bovines and porcines ,(2001)
Roland Cariolet, Evelyne Hutet, Claire Arnauld, Catherine Truong, Dominique Mahe, François Madec, Pierre Le Cann, Philippe Blanchard, Emmanuel Albina, André Jestin, Circovirus sequences associated with piglet weight loss disease (pwd) ,(2006)
Huiying Fan, Shaobo Xiao, Tiezhu Tong, Shengpin Wang, Lilan Xie, Yunbo Jiang, Huanchun Chen, Liurong Fang, Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments. Molecular Immunology. ,vol. 45, pp. 653- 660 ,(2008) , 10.1016/J.MOLIMM.2007.07.009
Richard J. McCoy, Jeffrey Michael Hammond, Michael G. Sheppard, Michael Anthony Johnson, Recombinant porcine adenovirus vector ,(1998)
Jeffrey Hammond, Michael A. Johnson, Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors ,(2007)